HKD 3.67
(-3.93%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 282.42 Million CNY | 60.74% |
2022 | 175.7 Million CNY | 199.11% |
2021 | 58.74 Million CNY | 188.31% |
2020 | 20.37 Million CNY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 229.74 Million CNY | 13.15% |
2024 Q1 | 229.74 Million CNY | -18.65% |
2023 Q3 | 259.2 Million CNY | -5.24% |
2023 FY | 282.42 Million CNY | 60.74% |
2023 Q1 | 251.21 Million CNY | 42.98% |
2023 Q2 | 273.53 Million CNY | 8.89% |
2023 Q4 | 282.42 Million CNY | 8.96% |
2022 Q3 | 164.39 Million CNY | 0.0% |
2022 Q4 | 175.7 Million CNY | 6.88% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 52.86 Million HKD | -434.218% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.93 Billion HKD | 95.238% |